• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926220250
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Congestive Heart Failure (1783); Death (1802); Cardiogenic Shock (2262); Respiratory Failure (2484)
Event Date 01/25/2017
Event Type  Death  
Manufacturer Narrative
Device is a combination product device evaluated by mfr: it is indicated that the device will not be returned for evaluation.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The cause of the reported difficulties could not be determined.(b)(4).
 
Event Description
(b)(4) clinical study.Same case as mfr report#: 2134265-2017-02334.It was reported that post a coronary artery drug eluting stenting treatment procedure, the patient expired.The subject was referred for cardiac catheterization and in december 2016, the index procedure was performed.Target lesion #1 was located in the proximal lad with 80% stenosis and was 15 mm long with a reference vessel diameter of 2.5 mm.Target lesion #1 was treated with direct placement of a 2.50 x 20 mm study stent and the residual stenosis was 0%.Target lesion #2 was located in the ramus with 70% stenosis and was 28 mm long with a reference vessel diameter of 2.25 mm.Target lesion #2 was treated with direct placement of a 2.25 x 32 mm study stent and the residual stenosis was 10%.The patient was discharged on dual antiplatelet therapy (aspirin and clopidogrel) 7 days later.In (b)(6) 2017, event of death was reported.The patient had acute respiratory failure that led to death.No additional information and source documents are available at this point of time.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that per death certificate acute respiratory failure, cardiogenic shock, congestive heart failure and diabetes mellitus were stated as the cause of death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6437322
MDR Text Key70966888
Report Number2134265-2017-02333
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/02/2017
Device Model NumberH7493926220250
Device Catalogue Number39262-2025
Device Lot Number18788313
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/06/2017
Initial Date FDA Received03/27/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/05/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/19/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age81 YR
-
-